中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 7
Jul.  2021
Turn off MathJax
Article Contents

Establishment of a model for evaluating the severity of nonalcoholic fatty liver disease based on transient elastography parameters

DOI: 10.3969/j.issn.1001-5256.2021.07.027
Research funding:

National Natural Science Foundation of China Grant (81902115);

National Key Research and Development Program of China (SQ2020YFF0426358);

National Science and Technology Major Project for Infectious Diseases (2017ZX10302201);

National Science and Technology Major Project for Infectious Diseases (2017ZX10202203);

China Postdoctoral Science Foundation (2017M620802);

Beijing Municipal Science & Technology Commission (Z161100000116047)

  • Received Date: 2020-11-20
  • Accepted Date: 2021-01-11
  • Published Date: 2021-07-20
  •   Objective  To establish a model for evaluating the severity of nonalcoholic fatty liver disease (NAFLD) based on a combined analysis of transient elastography parameters.  Methods  A retrospective analysis was performed for the clinical information and liver elasticity parameters of 184 NAFLD patients who attended 7 hospitals in China from July 2014 to July 2017 and underwent liver biopsy for pathological diagnosis. Liver elasticity parameters were named as P1-P18 according to the amplitude, frequency, dispersion, and attenuation of ultrasound signals. The Spearman rank correlation test and the linear regression analysis were used to establish the models for evaluating steatosis degree, inflammatory activity, and fibrosis degree, and the receiver operating characteristic (ROC) curve was used to evaluate the value of each diagnostic model.  Results  The ultrasound parameters based on transient elastography were well correlated with steatosis degree, inflammatory activity, and liver fibrosis degree in NAFLD patients. The multivariate analysis showed that P1 and P12 were independent indicators for predicting steatosis degree; P1, P3, P6, and P11 were independent indicators for predicting inflammatory activity; P2 and P3 were significantly correlated with liver fibrosis degree. The model Y=0.013×P1+0.055×P12-0.318 5 for predicting steatosis degree established based on linear regression had an area under the ROC curve (AUC) of 0.895 (95% confidence interval [CI]: 0.842-0.936) and 0.939 (95%CI: 0.894-0.969), respectively, in the diagnosis of mild steatosis and moderate-to-severe steatosis, with a sensitivity of 82.35% and 86.26%, respectively, and a specificity of 89.23% and 93.27%, respectively (P < 0.001). The model Y=0.008×P1+0.030×P3+0.029×P6-1.875×10-4×P11+0.416 for predicting inflammatory activity had an AUC of 0.828 (95%CI: 0.793-0.865) and 0.874 (95%CI: 0.817-0.918), respectively, in the diagnosis of early-stage inflammation and significant inflammation, with a sensitivity of 70.6% and 73.96%, respectively, and a specificity of 85.7% and 93.33%, respectively (P < 0.001). The model Y=-0.003×P1 + 0.601×(lnP2)+0.285×(lnP3)+0.036×P15 + 0.078 for predicting liver fibrosis degree had an AUC of 0.805 (95%CI: 0.740-0.869), 0.767 (95%CI: 0.699-0.827), and 0.803 (95%CI: 0.701-0.906), respectively, in the diagnosis of significant fibrosis, severe fibrosis, and early liver cirrhosis, with a sensitivity of 72.27%, 77.63%, and 90.00%, respectively, and a specificity of 79.69%, 66.42%, and 66.47%, respectively (P < 0.001).  Conclusion  Different parameters of transient elastography can effectively reflect steatosis degree, inflammatory activity, and fibrosis degree in NAFLD patients, and a combined model can improve the accuracy of disease severity prediction in NAFLD patients.

     

  • loading
  • [1]
    Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association; National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, et al. Expert recommendations on standardized diagnosis andtreatment for fatty liver disease(2019 revised edition)[J]. J Clin Hepatol, 2019, 35(11): 2426-2430. DOI: 10.3969/j.issn.1001-5256.2019.11.007.

    中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会, 中华医学会肝病学分会脂肪肝与酒精性肝病学组, 等. 脂肪性肝病诊疗规范化的专家建议(2019年修订)[J]. 临床肝胆病杂志, 2019, 35(11): 2426-2430. DOI: 10.3969/j.issn.1001-5256.2019.11.007.
    [2]
    YOUNOSSI ZM, KOENIG AB, ABDELATIF D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1): 73-84. DOI: 10.1002/hep.28431.
    [3]
    ESTES C, ANSTEE QM, ARIAS-LOSTE MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030[J]. J Hepatol, 2018, 69(4): 896-904. DOI: 10.1016/j.jhep.2018.05.036.
    [4]
    DIEHL AM, DAY C. Cause, Pathogenesis, and treatment of nonalcoholic steatohepatitis[J]. N Engl J Med, 2017, 377(21): 2063-2072. DOI: 10.1056/NEJMra1503519.
    [5]
    DULAI PS, SINGH S, PATEL J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis[J]. Hepatology, 2017, 65(5): 1557-1565. DOI: 10.1002/hep.29085.
    [6]
    ANGULO P, KLEINER DE, DAM-LARSEN S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease[J]. Gastroenterology, 2015, 149(2): 389-397. e10. DOI: 10.1053/j.gastro.2015.04.043.
    [7]
    ZHENG KI, LIU WY, PAN XY, et al. Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels[J]. BMJ Open Diabetes Res Care, 2020, 8(1): e001174. DOI: 10.1136/bmjdrc-2020-001174.
    [8]
    European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease[J]. Obes Facts. 2016, 9(2): 65-90. DOi: 10.1159/000443344.
    [9]
    BEDOSSA P, FLIP Pathology Consortium. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease[J]. Hepatology, 2014, 60(2): 565-575. DOI: 10.1002/hep.27173.
    [10]
    HAGSTRÖM H, NASR P, EKSTEDT M, et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD[J]. J Hepatol, 2017, 67(6): 1265-1273. DOI: 10.1016/j.jhep.2017.07.027.
    [11]
    National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: A 2018 update[J]. J Clin Hepatol, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.

    中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.
    [12]
    CASTERA L, FRIEDRICH-RUST M, LOOMBA R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease[J]. Gastroenterology, 2019, 156(5): 1264-1281. e4. DOI: 10.1053/j.gastro.2018.12.036.
    [13]
    SHEN F, ZHENG RD, MI YQ, et al. Value of a two-step approachwith cytokeratin-18 and controlled attenuation parameter in noninvasive differential diagnosis of nonalcoholic steatohepatitis[J]. Chin J Hepatol, 2016, 24(6): 429-434. DOI: 10.3760/cma.j.issn.1007-3418.2016.06.007.

    沈峰, 郑瑞丹, 宓余强, 等. 细胞角蛋白-18联合受控衰减参数二步法无创鉴别非酒精性脂肪性肝炎的临床研究[J]. 中华肝脏病杂志, 2016, 24(6): 429-434. DOI: 10.3760/cma.j.issn.1007-3418.2016.06.007.
    [14]
    WANG L, ZHU M, CAO L, et al. Liver stiffness measurement can reflect the active liver necroinflammation in population with chronic liver disease: A real-world evidence study[J]. J Clin Transl Hepatol, 2019, 7(4): 313-321. DOI: 10.14218/JCTH.2019.00040.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(5)

    Article Metrics

    Article views (615) PDF downloads(115) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return